Drug Discovery Enzymes Market

Future Market Insights

Key Insight

The drug discovery enzymes market is projected to grow from USD 1.1 billion in 2025 to USD 1.9 billion by 2035, at a CAGR of 6.2%. Active Kinases will dominate with a 41.7% market share, while pharmaceutical and biotechnology company will lead the end user segment with a 59.3% share.

September 23, 2025

Anurag Sharma

306 Pages

Cite this Report

Drug Discovery Enzymes Market

https://www.futuremarketinsights.com/reports/drug-discovery-enzymes-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Actelion Pharmaceuticals Ltd
Agilent Technologies
Biotechnology
Genesis Biotechnology Group
Kaneka Corporation
The Vanguard Group
Suven Life Sciences Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Drug Discovery Enzymes Market

Key Players

Similar Industry Reports